Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Skin Neoplasms 1Pancreatic Neoplasms 1Melanoma 1

Interventions

sargramostim 2aldesleukin 2Flow Cytometry 2Cyclophosphamide 2tislelizumab 1milademetan 1fludarabine phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1Tacrolimus 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Moxifloxacin 1Methylprednisolone 1Levofloxacin 1Interleukin-12 Subunit p35 1Interferon-alpha 1In Situ Hybridization 1Immunologic Techniques 1Immunoenzyme Techniques 1Granisetron 1Etoposide 1ER 30346 1Dexamethasone 1Data Collection 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Germ Cell Tumor × In Situ Hybridization × Dermatologic × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡